
    
      Design: Prospective, observational study. All cancer patients of the above mentioned cancer
      types receiving an anticancer treatment with curative intent will be asked to participate to
      this study. Consenting patients will undergo serial assessment at baseline, and 6 months
      after inclusion. Patient will be screened by the Distress Thermometer and 38-item Problem
      List followed by a neuropsychological assessment and self-assessment tools.
    
  